Higher angiotensin-converting enzyme 2 (ACE2) levels in the brain of individuals with Alzheimer's disease.

"Declarations Ethics approval and consent to participateAll procedures performed with volunteers included in this study were in accordance with the ethical standards of the institutional ethics committees and with the 1964 Helsinki Declaration. Written informed consent was obtained from all individual participants included in this study. All procedures relating to mouse care and experimental treatments were approved by the Laval University animal research committee (CPAUL) in accordance with the standards of the Canadian Council on Animal Care. Consent for publicationNot applicable. Competing interestsThe authors report no competing interests. Competing interests The authors report no competing interests."

"Funding Funding was provided by the Canadian Institutes of Health Research (CIHR) (MOP 125930) and by The Canadian Consortium on Neurodegeneration in Aging (CCNA) to F.C. The study was supported in part by P30AG10161, P30AG72975, R01AG15819, and R01AG58639 (D.A.B). F.C is a Fonds de recherche du Quebec—Sante (FRQ-S) senior research scholar."